What I didn’t understand the first time I researched my myelofibrosis diagnosis

I soon realized I was looking for certainty in a place that cannot give it

Written by Jamie Mussett Harford |

New column banner

The first thing I was told after hearing the words “You have cancer” was not to Google it. The first thing I did was Google it.

It was instinctive. I was trying to take control of something that had just knocked me off my feet, and information felt like the only way to do that. But with myelofibrosis, that instinct does not bring clarity. It brings confusion.

I spent hours poring over forums, reading patient stories, and scanning medical pages, trying to piece together what my future might look like. At first, it felt reassuring that people were talking openly about it. That feeling did not last long.

None of their experiences matched.

Recommended Reading
A graph labeled Clinical Trial shows large gains and is framed by a stethoscope, a pair of hands, and a scattering of pills.

Drug combo outperforms standard myelofibrosis treatment in trial

One person aged 65 had been living with it for years, with relatively few issues. Another was my age, 36, and already preparing for transplant. Some talked about fatigue and an enlarged spleen as if those were the main problems. Others were dealing with transfusions, blood clots, and rapid disease progression.

They were all describing the same disease, but it didn’t feel like the same experience.

That was when it started to sink in that myelofibrosis is not one clean diagnosis but a label that covers a wide range of biological realities. That variation is not subtle. It is fundamental.

Then the acronyms started appearing everywhere: JAK2 (Janus kinase 2), CALR (calreticulin), MPL (myeloproliferative leukemia virus oncogene).

At first, they read like technical details that could be ignored. In reality, they are the difference between understanding a situation and getting completely lost in someone else’s.

Gene mutations are not just classifications. They influence how the disease behaves, how it progresses, and how it responds to treatment. Two people can have myelofibrosis and be on entirely different paths.

That was the real mistake I made early on. I was trying to map my situation onto other people’s stories without understanding whether we were even dealing with the same underlying biology.

Understanding my own disease profile was key

Once my own results came back, things started to settle.

The question stopped being “What is myelofibrosis?” and became “What version of this do I have?”

The forums became more useful once I understood what applied to me and what did not. The medical language became less abstract once I could relate it back to my own numbers. The variation that felt overwhelming at the start began to make sense.

Something else also became clear quite quickly: Most of the information available is either too general to be useful or too specific to someone else’s situation to apply. That gap is where most of the anxiety sits.

I found myself looking for certainty in a place that cannot give it.

Looking back, the hardest part was not the diagnosis itself. It was the period immediately after, when I was trying to orient myself with too much information and not enough context. I was effectively trying to build a picture of my future using fragments of stories that were never designed to fit together.

If there is one thing I have taken from that stage, it is this: Understanding my own profile mattered more than anything else. What was driving the disease, what my blood counts were doing, and what my doctors were actually saying about my case. That became the foundation. Everything else started to make sense once that was clear.

So when people say not to Google, I am not convinced they really understand what they mean. What they are usually trying to say is to avoid looking at worst-case scenarios and statistics taken out of context.

What I found was something different. Not clarity, but noise. The process of learning how to filter it became the first real step in understanding the disease.


Note: Myelofibrosis News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The opinions expressed in this column are not those of Myelofibrosis News or its parent company, Bionews, and are intended to spark discussion about issues pertaining to myelofibrosis.